文献速递神经肿瘤

IDH野生型胶质母细胞瘤中Ki-67/MIB-1标记指数低表达独立于MGMT甲基化状态预测延长生存

Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
PubMed 文献 · J Neurooncol · 2023-05-25

该回顾性研究纳入2016年1月至2021年12月在本机构接受手术及Stupp方案治疗的119例IDH野生型胶质母细胞瘤患者,采用最小P值法确定Ki-67/MIB-1标记指数截断值。多因素分析显示Ki-67/MIB-1标记指数<15%与更长的总生存期显著相关,且独立于年龄、卡氏功能状态评分、手术切除程度及O6-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化状态。

要点

  • 在119例IDH野生型胶质母细胞瘤患者中,Ki-67/MIB-1标记指数<15%与更长的总生存期显著相关。
  • 该预后关联独立于年龄、卡氏功能状态评分、手术切除程度及MGMT启动子甲基化状态。
  • 作者提出Ki-67/MIB-1标记指数可作为该亚型胶质母细胞瘤的新预测标志物。

核心结论

  • 在IDH野生型胶质母细胞瘤患者中,Ki-67/MIB-1标记指数<15%与更长的总生存期显著相关,且独立于年龄、卡氏功能状态评分、手术切除程度及MGMT启动子甲基化状态。
  • 作者提出Ki-67/MIB-1标记指数可作为该亚型胶质母细胞瘤的新预测标志物。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2021年12月在本机构接受手术及Stupp方案治疗的119例IDH野生型胶质母细胞瘤患者。
  • 采用最小P值法确定Ki-67/MIB-1标记指数的截断值。

主要发现

  • 多因素分析显示,Ki-67/MIB-1标记指数<15%与更长的总生存期显著相关,且独立于年龄、卡氏功能状态评分、手术切除程度及MGMT启动子甲基化状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Ki-67/MIB-1 labeling index (LI) is clinically used to differentiate between high and low-grade gliomas, while its prognostic value remains questionable. Glioblastoma (GBM) expressing wild-type isocitrate dehydrogenase IDHwt, a relatively common malignant brain tumor in adults, is characterized by a dismal prognosis. Herein, we have retrospectively investigated the prognostic role of Ki-67/MIB-1-LI in a large group of IDHwt GBM. METHODS: One hundred nineteen IDHwt GBM patients treated with surgery followed by Stupp's protocol in our Institution between January 2016 and December 2021 were selected. A cut-off value for Ki-67/MIB-1-LI was used with minimal p-value based approach. RESULTS: A multivariate analysis showed that Ki-67/MIB-1-LI expression < 15% significantly correlated with a longer overall survival (OS), independently from the age of the patients, Karnofsky performance status scale, extent of surgery and O6-methylguanine (O6-MeG)-DNA methyltransferase promoter methylation status. CONCLUSIONS: Among other studies focused on Ki-67/MIB-1-LI, this is the first observational study showing a positive correlation between OS of IDHwt GBM patients and Ki-67/MIB-1-LI that we propose as a new predictive marker in this subtype of GBM.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Tini P, Yavoroska M, Mazzei MA, et al. Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status. J Neurooncol. 2023. PMID: 37227648. doi:10.1007/s11060-023-04342-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。